Skip to content


  • Case report
  • Open Access

“Pulmonary Actinomycosis attributable to Actinomyces meyeri presenting as cardiac tamponade: a case report”

  • 1Email author,
  • 2,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Multidisciplinary Respiratory Medicine201813:19

Received: 18 January 2018

Accepted: 21 May 2018

Published: 14 June 2018



Recently, it is reported that Actinomyces meyeri is the most common species causing actinomycosis. However, to our knowledge, there was no report about pulmonary actinomycosis attributable to A. meyeri presenting as cardiac tamponade.

Case presentation

Hereby we describe a case of pulmonary actinomycosis attributable to A. meyeri presenting as cardiac tamponade. At first, the patient was diagnosed with bacterial pericarditis with lung abscess in the left lower lung lobe and underwent pericardial drainage. Three days after the removal of the drainage tube, atrial fibrillation followed by cardiac arrest with asystole occurred and immediate cardiopulmonary resuscitation restored his circulation. Thereafter, he underwent pneumocentesis of the lung abscess and the culture grew A. meyeri. He was successfully treated with penicillin G.


This is the first case of pulmonary actinomycosis attributable to A. meyeri presenting as cardiac tamponade. We believe that an increased awareness of the disease is necessary to expedite diagnosis therefore minimizing morbidity and mortality.


  • Actinomyces meyeri
  • Cardiac tamponade
  • Lung abscess
  • Actinomycosis


Until recently, it was thought that Actinomyces israelii was the most common cause of actinomycosis, and A. meyeri was a rare causative agent. However, recently, Rolfe R et al. reported that A. meyeri might be a more common cause of actinomycosis than previously recognized [1]. In their report, A. meyeri was more common than A. israelii in 130 patients (43 and 30%, respectively) who had a positive result for Actinomyces cultures with adequate follow up in the Medical University of South Carolina between 1988 and 2016.

Actinomycosis is an indolent, slowly progressive bacterial infectious disease due to Actinomyces species [2]. Actinomycosis usually involves the cervicofacial (55%), abdomino-pelvic (20%), thoracic (15%), and mixed organ involvement (10%) including the skin, brain, pericardium and, extremities [3]. Actinomyces species are one of the normal bacterial flora of man’s oral cavity, and aspiration, trauma and poor dental hygiene are predisposing factors for initial infection [47]. It was reported that infections due to A. meyeri were more prevalent among males (the male-to-female ratio was 20:6), the mean age of patients was 42.5 years (range, 13–70 years), and dentogingival disease was a major risk factor for the development of infections, as with other actinomycoses [8, 9].

A. meyeri are prone to disseminated actinomycosis (defined as the involvement of two distant organs) [8]. But, to our knowledge, there was no report about pulmonary actinomycosis attributable to A. meyeri presenting as cardiac tamponade.

Case presentation

A 56-year-old Japanese male was referred to our hospital with dyspnea and hypotension. He had a history of Parkinson’s disease with psychosis. He complained of left-sided chest pain and productive cough in the 2 months before admission. He reported no risk factors for HIV infection, occasional alcohol consumption, and was a current smoker with a 30-pack/year smoking history. Initial vital signs were as follows: blood pressure, 77/56 mmHg; heart rate, 106/min; body temperature, 36.1 °C (97.0 °F). There was no lymphadenopathy or hepatosplenomegaly. Examination of the oral cavity revealed poor dentition and inadequate hygiene. Jugular venous pressure was elevated to the angle of the jaw at 45° and did not change with respirations. The breath sounds attenuated at both sides, and dullness was present at the base of the bilateral lung. Cardiovascular examination revealed regular rhythm, tachycardia, and distant heart sounds. Laboratory test values were as follows: white blood cells, 29,950/mm3 with a left shift; hemoglobin, 10.6 g/dl; platelets, 453,000/mm3; random serum glucose, 125 mg/dl (normal, 75–115 mg/dl); serum lactate dehydrogenase (LDH), 260 U/l (normal,119–229 U/l); serum aspartate and alanine aminotransferase (AST and ALT), 80 U/l and 24 U/l (normal, 0–35 U/l); serum albumin, 3.1 g/dl (normal, 4–5 g/dl); serum C-reactive protein (CRP), 17.25 mg/dl (normal, < 0.2 mg/dl). The chest radiograph (Fig. 1) revealed a mass in the left upper lung, bilateral pleural effusions and cardiac enlargement. The chest computed tomography (CT) scan showed a wedge-shaped and pleural-based mass in the left upper lobe (LUL), a thick-walled cavitary lesion containing only water density in the left lower lobe (LLL), bilateral pleural effusions and pericardial effusion (Fig. 2). An electrocardiogram was normal. The patient received acute pericardiocentesis and pericardial drainage tube placement, which yielded approximately 800 ml of dark yellow fluid and restored blood pressure. Thoracentesis on both sides was performed and revealed yellow and turbid pleural fluid. Gram stain and cytologic examination of both pericardial and pleural fluid showed no organisms and also malignant cells. Examination of sputum showed no pathogen on staining. Two sets of blood culture specimens drawn at the time of admission did not yield any organisms. The patient was initially diagnosed with a bacterial pericarditis and lung abscess in the LLL. Intravenous ceftriaxone was started as an empirical antimicrobial treatment.
Figure 1
Fig. 1

The chest radiograph revealed a mass in the left upper lung, bilateral pleural effusions and cardiac enlargement

Figure 2
Fig. 2

The chest CT scan showed a wedge-shaped and pleural-based mass in the left upper lobe (white arrow on (a), and black arrow on (b)), thick-walled cavitary lesion containing water density in the left lower lobe (white arrows on (c)), bilateral pleural effusions and pericardial effusion (* on (c))

After the admission, the patient continued to be afebrile and his respiratory and cardiovascular status was stable. On day 6, there was minimal pericardial fluid in the drainage tube so the drain was removed. In the morning of day 9, a fever of 39.0 °C (102.2 °F) and sinus tachycardia (150/min) occurred. The tachycardia continued for 4 h, and he experienced atrial fibrillation (Af). Immediately after the onset of Af, a cardiac arrest with asystole occurred. He underwent an immediate cardiopulmonary resuscitation, which restored sinus rhythm and blood pressure. Chest CT scan obtained on the same day revealed the remaining thick-walled cavitary lesion in the LLL and the reduced pericardial effusion. After the cardiopulmonary state was stabilized, he underwent ultrasound-guided pneumocentesis of the cavitary lesion in the LLL and 35 ml of purulent fluid was obtained (Fig. 3). Gram stain of the fluid revealed Gram-positive filamentous rods, and cultures of the fluid grew Actinomyces species (Fig. 3). We analyzed the fluid using a method for clone library sequencing of the 16S ribosomal DNA (rDNA) gene and Actinomyces meyeri along with other anaerobes (Fusobacterium species) were detected [10]. Transbronchial biopsy and bronchial washings of the mass lesion in both the LUL and LLL were performed. The biopsy revealed non-specific inflammation and organization of the lung tissue with no bacteria. On day 11, antibiotics were changed to intravenous penicillin, and his condition continued to be stable. After 4 weeks of intravenous penicillin therapy, antibiotics were switched to oral doxycycline therapy and he was discharged. Echocardiogram before the discharge showed no evidence of pericardial effusion or constrictive physiology. The patient completed the total six-month antibiotic therapy. At follow up, 6 months after discharge, the patient was gaining weight, felt well, and his CT images had continued to show improvement (Fig. 4).
Figure 3
Fig. 3

a The chest CT with enhancement on the 9th day showed a thick-walled cavitary lesion containing water density in the left lower lobe (white arrows) and a small amount of pericardial effusion; b Purulent fluid obtained by ultrasound-guided pneumocentesis of the cavitary lesion in the left lower lobe; c Gram stain of the fluid showed Gram-positive filamentous rods; d Cultures from the fluid grew Actinomyces species

Figure 4
Fig. 4

The chest CT scan after the completion of six-month antibiotic therapy showed a significant improvement


To our best knowledge, this is the first case report of pulmonary actinomycosis attributable to A. meyeri presenting as cardiac tamponade.In our patient, the pericarditis seemed to be caused by the direct extension of the inflammation from pulmonary actinomycosis, because we could not detect any microorganisms in the patient’s pericardial fluid. The arrhythmia which suddenly occurred in our patient and did not recur after the penicillin therapy suggests cardiac actinomycosis, however, evidence was not obtained.

Cardiac actinomycosis is very rare, and the frequency of this condition was reported as only 1.2 to 2% of all cases of actinomycosis [11, 12]. Cardiac actinomycosis was first reported in 1884 [13], and to date, two comprehensive reviews about this condition have been published. Cornell et al. documented 68 cases of cardiac actinomycosis and Fife et al. detailed 19 cases of pericardial actinomycosis documented [11, 14]. Cardiac involvement was usually caused by the direct extension of thoracic disease [15, 16]. In fact, it was reported that 23 out of 29 cases (79%) of pericardial actinomycosis since 1950 had thoracic involvement [17]. It is characterized by involvement of the pericardium, myocardium, and endocardium in a decreasing order of frequency, which is consistent with its mode of contiguous spread through tissue planes from the thorax [18]. Our patient had pulmonary lesions as primary sites of infection, and the pericardial involvement seemed to be caused by the direct extension from the primary sites However, in our patient, pericardial fluid did not show the evidence of A. meyeri infection. Actually, the diagnosis of actinomycosis is generally hampered by the difficulty in isolation and culture of the organism. It must be cultured in strictly anaerobic conditions. In the review of Fife et al., purulent pericardial fluid was obtained from 10 (53%) of 19 cases, however, Actinomyces species were successfully cultured from the fluid in only two of those 10 cases [14]. Similarly, low yields (26%) of biopsy specimen cultures have been observed [14]. Sulfur granules, long regarded as a histological hallmark of actinomycosis, are very strongly suggestive of the diagnosis. However, they are not entirely specific to actinomycosis, since these granules can also be found in nocardiosis, botryomycosis, aspergillosis, and coccidioidomycosis [4, 19]. Fortunately, gram stain of the purulent fluid obtained by pneumocentesis showed Gram-positive filamentous rods, and cultures from the purulent fluid grew Actinomyces species. Finally, the genetic testing with a method for clone library sequencing of the 16S rDNA gene of the fluid revealed A. meyeri along with Fusobacterium species. It was reported that two-thirds of the infections with A. meyeri were polymicrobial [8], and it was thought that reduced oxygen tension and inhibition of phagocytes induced by concomitant bacterial infections might enhance the pathogenicity of Actinomyces species [9].

In patients with cardiac actinomycosis, the prognosis is good when correct diagnosis and medical treatment are made, and appropriate choice of antibiotics and pericardial drainage are important. It was reported that when the diagnosis of cardiac actinomycosis was given and appropriate antibiotic therapy was started, 86% of patients survived [17]. The recommended antibiotic therapy is high doses of intravenous penicillin G (12–20 MU/d in divided doses) for 4 to 6 weeks, followed by 6 to 12 months of oral penicillin/amoxicillin [20]. Alternative choices in patients allergic to penicillin are sulfonamide, tetracycline, erythromycin, or third-generation cephalosporin. A. meyeri is also susceptible to most antibiotics, and penicillin remains the most cost-effective drug. The associated bacteria are generally susceptible to the antibiotics for the treatment of A. meyeri. According to the previous reports, a pericardial drainage or pericardiectomy was required in 82 and 45% of surviving patients, respectively. Our patient was successfully treated by pericardial drainage, pneumocentesis, and antibiotics.


To our knowledge, this is the first case who survived pulmonary actinomycosis attributable to A. meyeri presenting as cardiac tamponade. We believe that an increased awareness of the disease is necessary to expedite diagnosis therefore minimizing morbidity and mortality.



Atrial fibrillation

AST and ALT: 

Aspartate and alanine aminotransferase


C-reactive protein


Computed tomography


Lactate dehydrogenase


Left lower lobe


Left upper lobe


Ribosomal DNA


Authors’ contributions

All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Iizuka Hospital ethical committee.

Consent for publication

Written informed consent was obtained from all subjects for publication of this case report and accompanying images. A copy of the written consent is available for review upon requests.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan
Department of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan


  1. Rolfe R, Steed LL, Salgado C, Kilby JM. Actinomyces meyeri, a common agent of Actinomycosis. Am J med Sci. 2016;352:53–62.
  2. Prather JR, Eastridge CE, Hughes FA, McCaughan JJ. Actinomycosis of the thorax. Ann Thorac Surg. 1970;9:307–12.
  3. Hsieh MJ, Liu HP, Chang JP, Chang CH. Thoracic actinomycosis. Chest. 1993;104:366–70. URL: CHEST.
  4. Burden P. Actinomycosis. J Inf Secur. 1989;19:95–9. URL: Jounal of Infection.
  5. Conant EF, Wechsler RJ. Actinomycosis and nocardiosis of the lung. J Thorac Imaging. 1992;7:75–84. URL: Thoracic Imaging.
  6. Bennhoff D. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. 1984;94:1198–217. URL:Laryngoscope.;jsessionid=5CB49629A142E93328C95750E728E87E.f04t03
  7. Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med. 1977;63:666–73. URL: Am J Med.
  8. Apothéloz C, Regamey C. Disseminated infection due to Actinomyces meyeri: case report and review. Clin Infect Dis 1996;22:621–625. URL: Clin Infect Dis.
  9. Russo TA. Agents of actinomycosis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases Vol 2. 4th ed. New York: Churchill.Google Scholar
  10. Kawanami T, Fukuda K, Yatera K, Kido T, Yoshii C, Taniguchi H, et al. Severe pneumonia with Leptotrichia sp. detected predominantly in bronchoalveolar lavage fluid by use of 16S rRNA gene sequencing analysis. J Clin Microbiol. 2009;47:496–8.
  11. Cornell A, Shookhoff HB. Actinomycosis of the heart simulating rheumatic fever: report of 3 cases with a review of the literature. Arch Intern Med. 1944;74:11–27. URL:
  12. Kanna B, Anita S. Disseminated Actinomycosis with unusual cardiac involvement: case report and review. Infect Dis Clin Pract. 2002;11:408–13.
  13. Konig A. Inaugural dissertation. In: Berlin; 1884.Google Scholar
  14. Fife T, Finegold SM, Grennan T. Pericardial actinomycosis: case report and review. Rev Infect Dis 1991;13:120–126. URL: Clinical Infect Dis.
  15. Datta JS, Raff MJ. Actinomycotic pleuropericarditis. Am Rev Respir Dis. 1974;110:338–41. URL: Am Rev Respir Dis.
  16. Zoeckler S. Cardiac actinomycosis: a case report and review of the literature. Circulation 1951;3:854–858. URL: Circulation.
  17. Peters GL, Davies RA, Veinot JP, Burwash IG. Cardiac actinomycosis: an unusual cause of an intracardiac mass. J Am Soc Echocardiogr. 2006;19(12):1530.e7–11. URL: J Am Soc Echocardiogr.
  18. Dutton WE Inclan PA. Cardiac actinomycosis. Dis Chest. 1968;54:465–7. URL: Diseases of the Chest.
  19. Hooker TP, Hammond M, Corral K. Empyema necessitatis: review of the manifestations of thoracic actinomycosis. Cleveland Clin J Med. 1992;59:542–8. URL: Cleveland Clin J Med.
  20. Smego RA, Foglia G. Actinomycosis. Clin Infect Dis. 1998;26:1255–61.Google Scholar


© The Author(s). 2018